News Feed Opinion Blog Posts Career Updates Insight Dialogues Celebrities Oncolibrary
Positive Societies Drugs Stories History Cancer Center Near Me Cancer Types Immune Oncology Oncologist Near Me
August, 2025
August 2025
M T W T F S S
 123
45678910
11121314151617
18192021222324
25262728293031
Registration Is Open for the Annual Hematologic Malignancies Congress – NCCN
NCCN/LinkedIn
Aug 24, 2025, 08:18

Registration Is Open for the Annual Hematologic Malignancies Congress – NCCN

National Comprehensive Cancer Network (NCCN) shared a post on LinkedIn:

“Join us in San Diego this fall at the Hematologic Malignancies Congress. Hear from experts, including Naval G. Daver, MD, and Guillermo Garcia-Manero, MD, from MD Anderson Cancer Center as they discuss Evolving Treatment Strategies for Acute Myeloid Leukemia and more.

Register now.”

More posts featuring NCCN.

cancer Hematologic Malignancies Congress National Comprehensive Cancer Network NCCN OncoDaily Oncology
Special Coverage
Voices
Aug 24, 2025, 08:18
Registration Is Open for the Annual Hematologic Malignancies Congress - NCCN
Voices
Aug 24, 2025, 07:53
Carmen Monge-Montero: A Glimpse of the Powerful Conversation with Michael Holtz
Insight
Aug 24, 2025, 07:51
Kefah Mokbel: Update on the Management of Phyllodes Tumours
Voices
Aug 24, 2025, 07:38
Spotlight on Tenaye Alazar, Program Coordinator in Ethiopia - The Max Foundation
Insight
Aug 24, 2025, 07:13
Olivier Elemento: AI in Hematology - A 2025 Snapshot from ASH
Insight
Aug 24, 2025, 07:09
Arturo LoAIza-Bonilla: Co-Authoring Insights on Large Language Models in Radiation Oncology
Drugs
Aug 24, 2025, 05:59
Lonsurf (Trifluridine/Tipiracil): A Patient’s Guide 2025 to Treatment for Advanced Colorectal and Stomach Cancer
Drugs
Aug 24, 2025, 05:22
Lonsurf (trifluridine/tipiracil) 2025 Updates: Uses in Cancer, Side Effects, Dosage, Expectations, and More
Blog Posts
Aug 24, 2025, 05:05
Naveen Pemmaraju: Wonderful to Meet Friends and Colleagues at MPN meeting 2025
Insight
Aug 24, 2025, 04:55
Shilpa Gupta Shared Highlights from IBCG 2025
Voices
Aug 24, 2025, 03:00
Giuseppe Minniti: Gliofocus Phase 3 Trial Explores PARP Inhibitors with Radiotherapy in GBM
Voices
Aug 24, 2025, 01:32
Minhua Chu: Zelgen Biopharma’s ZGGS34 Gets FDA Approval for Solid Tumor Study